Micrus Endovascular Corporation Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	56
ISBN Number	not applicable
Product Code	GMD04792

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Micrus Endovascular Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Overview
- 2.1 Key Information
- 2.2 Industry Outlook Cardiovascular Devices
3 Major Products and Services
- 3.1 Overview
4 Competitors
5 Key Employees
6 Locations And Subsidiaries
- 6.1 Head Office
- 6.2 Other Locations & Subsidiaries
7 Recent Developments
- 7.1 Financial Announcements
  - 7.1.1 Aug 07, 2008: Micrus Reports 1Q Fiscal 2009 Results
  - 7.1.2 May 08, 2008: Micrus Reports Q4 Fiscal 2008 Results
  - 7.1.3 Feb 07, 2008: Micrus Reports Q3 Fiscal 2008 Results
  - 7.1.4 Nov 08, 2007: Micrus Declares Q2 Fiscal 2008 Results
  - 7.1.5 Aug 07, 2007: Micrus Reports Q1 Fiscal 2008 Results
  - 7.1.6 May 10, 2007: Micrus Reports Q4 Fiscal 2007 Results
  - 7.1.7 Feb 12, 2007: Micrus Reports Q3 Fiscal 2007 Results
  - 7.1.8 Nov 13, 2006: Micrus Reports Q2 Fiscal 2007 Results
  - 7.1.9 Aug 14, 2006: Micrus Reports Q1 Fiscal 2007 Results
- 7.2 Corporate Communications
  - 7.2.1 Nov 08, 2007: Micrus Appoints CFO
  - 7.2.2 Sep 25, 2007: Micrus Joins NASDAQ NeuroInsights Neurotech Index
  - 7.2.3 Sep 24, 2007: Micrus Announces Management Changes
  - 7.2.4 Sep 24, 2007: Micrus Announces Management Changes
  - 7.2.5 Nov 20, 2006: Micrus Appoints Board Members
- 7.3 Product News
  - 7.3.1 Jul 14, 2008: Micrus Endovascular Receives FDA Approval For Intracranial Stent Clinical Trial
  - 7.3.2 Jul 10, 2008: Micrus Endovascular Receives Approval To Market Cerecyte Microcoils In Japan
  - 7.3.3 Jun 23, 2008: Micrus Endovascular Announces CE Mark For PHAROS Vitesse Stent
  - 7.3.4 Jan 17, 2008: Micrus Endovascular And Genesis Medical Interventional Sign License, Development And Commercialization Agreement
  - 7.3.5 May 29, 2007: Micrus Endovascular Receives FDA Clearance for the ENZO Steerable Microcatheter
  - 7.3.6 May 16, 2006: Micrus Endovascular Receives FDA Clearance For Courier Microcatheter
  - 7.3.7 May 13, 2006: Micrus Endovascular Receives CE Mark Clearance For Watusi Guidewire
  - 7.3.8 May 11, 2006: Micrus Endovascular Receives FDA Clearance For Watusi Guidewire
  - 7.3.9 Mar 13, 2006: Micrus Endovascular Receives CE Mark Clearance For Courier Microcatheter And Watusi Guidewire
  - 7.3.10 Nov 21, 2005: Micrus Endovascular Launches Presidio Microcoil To Treat Large, Irregular Cerebral Aneurysm
- 7.4 Product Approvals
  - 7.4.1 Jul 10, 2008: Micrus Endovascular Receives Approval To Market Cerecyte Microcoils In Japan
  - 7.4.2 Jun 23, 2008: Micrus Endovascular Announces CE Mark For PHAROS Vitesse Stent
  - 7.4.3 May 29, 2007: Micrus Endovascular Receives FDA Clearance for the ENZO Steerable Microcatheter
  - 7.4.4 May 16, 2006: Micrus Endovascular Receives FDA Clearance For Courier Microcatheter
  - 7.4.5 May 13, 2006: Micrus Endovascular Receives CE Mark Clearance For Watusi Guidewire
  - 7.4.6 May 11, 2006: Micrus Endovascular Receives FDA Clearance For Watusi Guidewire
  - 7.4.7 Mar 13, 2006: Micrus Endovascular Receives CE Mark Clearance For Courier Microcatheter And Watusi Guidewire
- 7.5 Clinical Trials
  - 7.5.1 Jul 14, 2008: Micrus Endovascular Receives FDA Approval For Intracranial Stent Clinical Trial
- 7.6 Other Significant Developments
  - 7.6.1 Aug 01, 2007: Micrus Signs Distribution Agreement With TXF Medical
  - 7.6.2 Jan 09, 2006: BIOTRONIK Signs Development And Distribution Agreement With Micrus
8 Micrus Endovascular Corporation Pipeline Products
- 8.1 Micrus Endovascular Corporation Product Pipeline Analysis
  - 8.1.1 Micrus Endovascular Corporation Pipeline Products By Equipment Type
  - 8.1.2 Micrus Endovascular Corporation Pipeline Products By Development Stage
  - 8.1.3 Micrus Endovascular Corporation Pipeline Products By Therapy Area
  - 8.1.4 Micrus Endovascular Corporation Pipeline Products By Clinical Trials
  - 8.1.5 Micrus Endovascular Corporation Pipeline Products By News Summary
- 8.2 Pharos Stent
  - 8.2.1 Product Description
  - 8.2.2 Product Status
  - 8.2.3 Product Milestone
- 8.3 MicruSphere Microcoil
  - 8.3.1 Product Description
  - 8.3.2 Product Status
- 8.4 HeliPaq & HeliPaq SR Microcoil
  - 8.4.1 Product Description
  - 8.4.2 Product Status
- 8.5 Presidio Microcoil
  - 8.5.1 Product Description
  - 8.5.2 Product Status
  - 8.5.3 Product Milestone
- 8.6 InterPaq Microcoil
  - 8.6.1 Product Description
  - 8.6.2 Product Status
- 8.7 ACT MicroCoil Delivery System
  - 8.7.1 Product Description
  - 8.7.2 Product Status
- 8.8 Courier Microcatheter
  - 8.8.1 Product Description
  - 8.8.2 Product Status
  - 8.8.3 Product Milestone
- 8.9 Cerecyte Microcoil
  - 8.9.1 Product Description
  - 8.9.2 Product Status
  - 8.9.3 Clinical Trials
  - 8.9.4 Product Milestone
- 8.10 UltiPaq Microcoil
  - 8.10.1 Product Description
  - 8.10.2 Product Status
- 8.11 Microcoils (next generation)
  - 8.11.1 Product Description
  - 8.11.2 Product Status
- 8.12 Next-generation balloon expandable stents
  - 8.12.1 Product Description
  - 8.12.2 Product Status
- 8.13 Self-expanding stents
  - 8.13.1 Product Description
  - 8.13.2 Product Status
- 8.14 Covered Stent
  - 8.14.1 Product Description
  - 8.14.2 Product Status
- 8.15 Liquid embolic product
  - 8.15.1 Product Description
  - 8.15.2 Product Status
- 8.16 Occlusion balloons
  - 8.16.1 Product Description
  - 8.16.2 Product Status
9 Appendix
- 9.1 Methodology
  - 9.1.1 Coverage
  - 9.1.2 Secondary Research
  - 9.1.3 Primary Research
  - 9.1.4 Expert Panel Validation
- 9.2 Contact Us
- 9.3 About Global Markets Direct
- 9.4 Disclaimer
1 List of Tables
- Table 1: Micrus Endovascular Corporation,Key Facts
- Table 2: Micrus Endovascular Corporation, Key Employees,
- Table 3: Micrus Endovascular Corporation, Other Locations
- Table 4: Micrus Endovascular Corporation Pipeline Products by Equipment Type
- Table 5: Micrus Endovascular Corporation Pipeline Products By Development Stage
- Table 6: Micrus Endovascular Corporation Pipeline Products By Therapy Area
- Table 7: Micrus Endovascular Corporation Pipeline Products By Clinical Trials
- Table 8: Micrus Endovascular Corporation Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Micrus Endovascular Corporation Pipeline Products By Development Stage
- Figure 2: Micrus Endovascular Corporation Pipeline Products By News Summary
- Figure 3: Global Markets Direct Methodology